Intermediate filaments (IFs) are one of the three major components of the cytoskeleton in metazoan cells, alongside actin microfilaments and microtubules. Unlike the latter, whose functions in cell structure and dynamics are well characterized, the roles of IFs remain only partly understood. A key feature that distinguishes IFs from other cytoskeletal components is their composition: they are formed by cell-type-specific proteins. In cardiac myocytes, the primary IF protein is desmin, which plays a critical role in maintaining cellular integrity, mechanical stability, and alignment of contractile apparatus.
Our research has revealed consistent patterns of post-translational modifications (PTMs) of desmin, particularly phosphorylation, in both experimental models and clinical samples of heart failure (HF). These PTMs are frequently associated with cardiac dysfunction and suggest a pathophysiological role for modified desmin in the HF.
In addition to PTMs—and potentially closely linked to them—we have observed a disruption of desmin homeostasis, characterized by the accumulation of large intracellular aggregates and pre-amyloid oligomers (PAOs). These aberrant desmin aggregates could impair cytoskeletal organization and compromise the mechanical and structural functions of cardiomyocytes, thereby contributing to disease progression.
A major objective of our work is to investigate how both desmin modifications and its impaired homeostasis contribute to the onset and development of HF. Through integrated studies in animal models and human tissues, we aim to elucidate the molecular mechanisms by which dysfunctional desmin affects cardiac structure and performance, ultimately identifying novel therapeutic targets for HF treatment.